Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. (Q46837832)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. |
scientific article |
Statements
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients (English)
Rita Engenhart-Cabillic
Emmanouil Fokas
Lin-Fang Wang
Michael Bieker
Frank Rose
Peter Rexin
Yuan Zhu
Han-Xiang An
1 January 2008